Back to Search
Start Over
Oral Administration of Lactobacillus casei and Bifidobacterium bifidum Improves Glucagon like Peptide-1(GLP-1) and Glucose-Dependent Insulinotropic Polypeptide (GIP) Level in Streptozotocin Induced Diabetic Rats
- Source :
- Current Research in Nutrition and Food Science Journal. 9:431-440
- Publication Year :
- 2021
- Publisher :
- Enviro Research Publishers, 2021.
-
Abstract
- The gut microbiome plays significant role in the function and integrity of the gastrointestinal tract. They also maintain immune homeostasis and host energy metabolism. The metabolic products of these intestinal microbes can alter carbohydrate metabolism, nutrient absorption and reduce appetite to promote healthy lifestyle. Intestinal disbiosis observed in metabolic disorders like obesity and diabetes. Restoration of dysbiosed gut microbiome through oral administration of probiotics that may have profound health effect in diabetes. In case of diabetes, reports postulated impaired level of incretin, therefore we explored the effect of oral administration of probiotic bacteria Lactobacillus casei NCDC 017 (LC017) and Bifidobacterium bifidum NCDC 231 (BB231) alone and in combination on secretion of incretin hormones such as glucagon like peptide-1 and glucose dependent insulinotropic polypeptide. Thirty six male Wistar rats were randomly divided into six groups and diabetes was induced by single dose of streptozotocin (50 mg/kg body weight) in experimental rats intraperitonially except a group of healthy rats. The diabetic rats were daily administered orally with single dose (~107cfu/ml) of LC017 and BB231 alone and in combination for 28 days. Also, one group of diabetic rats was treated with an anti-diabetic drug, acarbose (10mg/kg body weight) and used a standard control. The change in body weight, sucrose tolerance test, GLP-1, GIP level in serum and GLP-1 level in different part of intestine were observed. The results have shown reduction in body weight in diabetic rats as compared to non-diabetic rats but improved after treatment of probiotic bacteria. Administration of LC017 and BB231 significantly improved GLP-1 and GIP level which were initially impaired in diabetic rats and their combination significantly decreased glucose level in sucrose tolerance test. This study indicated that LC017 and BB231 have significant hypoglycaemic potential in diabetic rats by increasing GLP-1 and GIP level. These findings offered a base for the use of LC017 and BB231 for improvement and treatment of diabetes.
- Subjects :
- medicine.medical_specialty
Lactobacillus casei
Bifidobacterium bifidum
biology
ved/biology
Chemistry
ved/biology.organism_classification_rank.species
Medicine (miscellaneous)
Streptozotocin
biology.organism_classification
Glucagon-like peptide-1
Endocrinology
Oral administration
Internal medicine
medicine
Glucose-dependent insulinotropic polypeptide
Food Science
medicine.drug
Subjects
Details
- ISSN :
- 23220007 and 2347467X
- Volume :
- 9
- Database :
- OpenAIRE
- Journal :
- Current Research in Nutrition and Food Science Journal
- Accession number :
- edsair.doi...........bbb52a77c22659a2d69d221025600d45